- Long|Term Risks of Intravenous Iron in End|Stage Renal Disease ...🔍
- Safety concerns about intravenous iron therapy in patients with ...🔍
- Intravenous iron in heart failure and chronic kidney disease🔍
- High dose intravenous iron🔍
- Safety of intravenous iron use in chronic kidney disease🔍
- Iron management in chronic kidney disease🔍
- Oxidative stress and renal injury with intravenous iron in patients ...🔍
- Intravenous Iron in Patients Undergoing Maintenance Hemodialysis🔍
Long|Term Risks of Intravenous Iron in End|Stage Renal Disease ...
Long-Term Risks of Intravenous Iron in End-Stage Renal Disease ...
Patients with end-stage renal disease on dialysis commonly receive intravenous iron to treat anemia along with erythropoiesis-stimulating agents.
Long-Term Risks of Intravenous Iron in End-Stage Renal Disease ...
Patients with end-stage renal disease on dialysis commonly receive intravenous iron to treat anemia along with erythropoiesis- stimulating agents.
Safety concerns about intravenous iron therapy in patients with ...
[52] demonstrated that therapy with iron sucrose accelerates early endothelial damage and subsequent atherosclerosis in mice with renal ...
Intravenous iron in heart failure and chronic kidney disease
Intravenous iron therapy is increasingly being used worldwide to treat anemia in chronic kidney disease and more recently iron deficiency in heart failure.
High dose intravenous iron: a note of caution - Oxford Academic
Iron potentially contributes to cardiovascular complications in end‐stage renal disease patients. Serum ferritin is a marker for morbidity and mortality in ...
Safety of intravenous iron use in chronic kidney disease
The direct toxic effect of iron on renal tubular cells appears greatest with iron sucrose and less with iron dextran and iron isomaltoside. The single-centre ...
overload in long-term hemodialysis patients and the impact of · withdrawing parenteral iron. ... risk factor for atherosclerosis in end-stage renal disease. Int ...
Oxidative stress and renal injury with intravenous iron in patients ...
Intravenous iron is widely prescribed in patients with chronic kidney disease (CKD) and can cause oxidative stress. The relationship of oxidative stress and ...
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis
However, intravenous iron therapy may cause harm by increasing the risks of infection, oxidative stress, vascular calcification, and ...
Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
Long-term Toxicity of IV Iron. There are no prospective ... Intravenous iron and the risk of infection in end-stage renal disease patients.
Long-Term Risks of Intravenous Iron in End-Stage Renal Disease ...
Until additional evidence is forthcoming, an iron deficiency state in patients with heart failure should be defined by a TSAT <20% (as long as the serum ...
Intravenous iron supplementation in end-stage renal disease patients
These data clearly indicate that sodium ferric gluconate can effectively improve iron status and anemia of dialysis patients. However, it provides only limited ...
Long-Term Risks of Intravenous Iron in End-Stage Renal Disease ...
... 4 This change in the management of anemia have led to concerns that increased use of m-IVFe may produce iron overload and contribute to ...
Oral or intravenous iron for anemia correction in chronic kidney ...
RCTs of small sample size in patients with end-stage renal disease receiving dialysis therapy that examined the effects of intravenous versus oral iron.
Intravenous Iron Therapy as a Possible Risk Factor for ... - J-Stage
C-IMT measurements correlated with serum ferritin and with the intravenous iron dose received during the 24 months preceding the study (r = 0.315, P = 0.015; r ...
Iron deficiency in people with chronic kidney disease can be ...
For people with chronic kidney disease who are also iron deficient, intravenous iron improves haemoglobin levels and iron stores faster than oral iron.
Intravenous iron dextran treatment in predialysis patients with ...
Long-term cardiorespiratory effects of amelioration of renal ... 23. Matzke, GR. Intravenous iron supplementation in end-stage renal disease patients.
IV Iron Therapy in CKD Increases Infection Risk
SAN DIEGO—Non-dialysis chronic kidney disease (CKD) patients receiving intravenous (IV) iron therapy may have increased risks for infection, ...
Venofer: Intravenous Iron Therapy (CAG-00080N) - Decision Memo
The study demonstrates the effectiveness of iron sucrose in treating iron deficiency anemia in hemodialysis patients on EPO. Results from the study indicate ...
Risk of Infection Associated With Administration of Intravenous Iron
Intravenous iron is recommended by clinical practice guidelines for the treatment of anemia associated with a range of common conditions, ...